TY - JOUR
T1 - Impact of hypertension stratified by diabetes on the lifetime risk of cardiovascular disease mortality in Japan
T2 - a pooled analysis of data from the Evidence for Cardiovascular Prevention from Observational Cohorts in Japan study
AU - on behalf of the Evidence for Cardiovascular Prevention from Observational Cohorts in Japan (EPOCH-JAPAN) Research Group
AU - Imai, Yukiko
AU - Hirata, Takumi
AU - Saitoh, Shigeyuki
AU - Ninomiya, Toshiharu
AU - Miyamoto, Yoshihiro
AU - Ohnishi, Hirofumi
AU - Murakami, Yoshitaka
AU - Iso, Hiroyasu
AU - Tanaka, Sachiko
AU - Miura, Katsuyuki
AU - Tamakoshi, Akiko
AU - Yamada, Michiko
AU - Kiyama, Masahiko
AU - Ueshima, Hirotsugu
AU - Ishikawa, Shizukiyo
AU - Okamura, Tomonori
N1 - Funding Information:
Funding This research was supported by a grant–in–aid from the Ministry of Health, Labor and Welfare, Health and Labor Sciences research grants, Japan (Research on Health Services: H17-Kenkou-007; Comprehensive Research on Cardiovascular Disease and Life-Related Disease: H18-Junkankitou [Seishuu]-Ippan-012; H19-Junkankitou [Seishuu]-Ippan-012; H20-Junkankitou [Seishuu]-Ippan-013; H23-Junkankitou [Seishuu]-Ippan-005; H26-Junkankitou [Sei-saku]-Ippan-001 and H29-Junkankitou-Ippan-003.
Publisher Copyright:
© 2020, The Japanese Society of Hypertension.
PY - 2020/12
Y1 - 2020/12
N2 - Lifetime risk is an informative estimate to motivate people to change lifestyle behaviors, especially from a younger age, in public health education. The impact of the combination of hypertension and diabetes on the lifetime risk of cardiovascular mortality has not been investigated in Asian populations. A pooled analysis of individual data from nine cohorts was performed. A total of 57,339 Japanese men and women were eligible for the analysis. We used the modified Kaplan–Meier approach and estimated the remaining lifetime risk of cardiovascular mortality starting from the index age of 35 years. Participants were classified into four categories defined by hypertension and diabetes. The lifetime risk was increased in the order of those without either risk, those without hypertension but with diabetes, those with hypertension but without diabetes, and those with both risks. The lifetime risk of cardiovascular mortality at the 35-year index age was as follows: 7.8% in men and 6.2% in women for those without either hypertension or diabetes, 13.2% in men and 9.5% in women for those without hypertension but with diabetes, 17.2% in men and 11.7% in women for those with hypertension but without diabetes, and 19.4% in men and 15% in women for those with both risks. These findings reinforce the need for a life-course perspective in the management of hypertension and diabetes from a younger age.
AB - Lifetime risk is an informative estimate to motivate people to change lifestyle behaviors, especially from a younger age, in public health education. The impact of the combination of hypertension and diabetes on the lifetime risk of cardiovascular mortality has not been investigated in Asian populations. A pooled analysis of individual data from nine cohorts was performed. A total of 57,339 Japanese men and women were eligible for the analysis. We used the modified Kaplan–Meier approach and estimated the remaining lifetime risk of cardiovascular mortality starting from the index age of 35 years. Participants were classified into four categories defined by hypertension and diabetes. The lifetime risk was increased in the order of those without either risk, those without hypertension but with diabetes, those with hypertension but without diabetes, and those with both risks. The lifetime risk of cardiovascular mortality at the 35-year index age was as follows: 7.8% in men and 6.2% in women for those without either hypertension or diabetes, 13.2% in men and 9.5% in women for those without hypertension but with diabetes, 17.2% in men and 11.7% in women for those with hypertension but without diabetes, and 19.4% in men and 15% in women for those with both risks. These findings reinforce the need for a life-course perspective in the management of hypertension and diabetes from a younger age.
UR - http://www.scopus.com/inward/record.url?scp=85087386009&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087386009&partnerID=8YFLogxK
U2 - 10.1038/s41440-020-0502-5
DO - 10.1038/s41440-020-0502-5
M3 - Article
C2 - 32620896
AN - SCOPUS:85087386009
SN - 0916-9636
VL - 43
SP - 1437
EP - 1444
JO - Hypertension Research
JF - Hypertension Research
IS - 12
ER -